Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Andersson, Amanda
DOB: 24-SEP-1984 (Age: 41)
Gender: female
Address:
Strandgränd 26
15110 Södertälje (Sweden)
ID: 7537-116766-1 (ECI)
Report
Date: 26-JAN-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Södertälje sjukhus
152 40 Södertälje (Sweden)
Specimen
Collected: 26-JAN-2018

Chemistry

Test 26-JAN-2018 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 188.5 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 129.7 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 105.8 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.7 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile shows mildly elevated LDL cholesterol (105.8 mg/dL), while total cholesterol, triglycerides, and HDL are within normal limits. This suggests a slightly increased cardiovascular risk. Recommend lifestyle modifications (diet, exercise) and follow-up lipid monitoring; clinical correlation advised. No acute abnormalities detected.